Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy

Journal of Gastrointestinal Surgery

Volumn 13, Issue 10, 2009, Pages 1821-1830

  Ojima, Toshiyasu ^a   Iwahashi, Makoto ^a   Nakamori, Mikihito ^a   Nakamura, Masaki ^a   Naka, Teiji ^a   Katsuda, Masahiro ^a   Iida, Takeshi ^a   Hayata, Keiji ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Blood transfusion; Gastric cancer

Indexed keywords

AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; FEMALE; GASTRECTOMY; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; STOMACH TUMOR; SURVIVAL;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 70350401759     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-0973-9     Document Type: Article

References (40)

1. Yamamoto J, Kosuge T, Takayama T et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115:303-309.
2. Hyman NH, Foster RS Jr, DeMeules JE, Costanza MC. Blood transfusions and survival after lung cancer resection. Am J Surg 1985;149:502-507.
3. Tartter PI, Burrows L, Papatestas AE, Lesnick G, Aufses AH Jr. Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 1985;97:225-230.
4. Jones KR, Weissler MC. Blood transfusion and other risk factors for recurrence of cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1990;116:304-309.
5. Foster RS Jr, Costanza MC, Foster JC, Wanner MC, Foster CB. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 1985;55:1195-1201.
6. Heal JM, Chuang C, Blumberg N. Perioperative blood transfusions and prostate cancer recurrence and survival. Am J Surg 1988;156:374-380.
7. Wu HS, Little AG. Perioperative blood transfusions and cancer recurrence. J Clin Oncol 1988;6:1348-1354.
8. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: Epidemiology, pathology and treatment. Ann Oncol 2003;14(suppl 2):ii31-36.
9. Sasako M, Sano T, Yamamoto S et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008;359:453-462.
10. Kampschöer GH, Maruyama K, Sasako M, Kinoshita T, van de Velde CJ. The effects of blood transfusion on the prognosis of patients with gastric cancer. World J Surg 1989;13:637-643.
11. Moriguchi S, Maehara Y, Akazawa K, Sugimachi K, Nose Y. Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer. Cancer 1990;66:2331-2335.
12. Choi JH, Chung HC, Yoo NC et al. Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gastric cancer. Oncology 1995;52:170-175.
13. Bortul M, Calligaris L, Roseano M, Leggeri A. Blood transfusions and results after curative resection for gastric cancer. Suppl Tumori 2003;2:S27-30.
14. Sánchez-Bueno F, García-Marcilla JA, Pérez-Abad JM, Vicente R, Aranda F, Lujan JA, Parrilla P. Does perioperative blood transfusion influence long-term prognosis of gastric cancer. Dig Dis Sci 1997;42:2072-2076.
15. Dhar DK, Kubota H, Tachibana M et al. A tailored perioperative blood transfusion might avoid undue recurrences in gastric carcinoma patients. Dig Dis Sci 2000;45:1737-1742.
16. Hyung WJ, Noh SH, Shin DW, Huh J, Huh BJ, Choi SH, Min JS. Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol 2002;9:5-12.
17. Kaneda M, Horimi T, Ninomiya M et al. Adverse affect of blood transfusions on survival of patients with gastric cancer. Transfusion 1987;27:375-377.
18. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994;167:256-260.
19. Maeta M, Shimizu N, Oka A et al. Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer. J Surg Oncol 1994;55:149-153.
20. Sobin LH, Wittekind CH. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors. 5th ed. New York: Wiley, 1997.
21. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-1136.
22. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-1295.
23. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005;42:100-107.
24. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
25. Erslev AJ. Erythropoietin and anemia of cancer. Eur J Haematol 2000;64:353-358.
26. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. 13th ed. Tokyo: Kanehara, 1999.
27. Jauch KW, Heiss MM, Gruetzner U et al. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol 1996;14:1810-1817.
28. Heiss MM, Simon EH, Beyer BC et al. Minimal residual disease in gastric cancer: Evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow. J Clin Oncol 2002;20:2005-2016.
29. Heiss MM, Allgayer H, Gruetzner KU et al. Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients. Anticancer Res 1997;17:2657-2661.
30. Kooby DA, Stockman J, Ben-Porat L et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003;237:860-869.
31. Sun CF, Hsieh YY, Ngan KW, Wang WT. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: Flow cytometry of Th1/Th2 cells in peripheral blood. Ann Clin Lab Sci 2001;31:171-178.
32. Baumgartner JM, Silliman CC, Moore EE, Banerjee A, McCarter MD. Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg 2009;208:110-119.
33. Zhang H, Chua KS, Guimond M et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med 2005;11:1238-1243.
34. Chen G, Zhang FJ, Gong M, Yan M. Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients. J Zhejiang Univ Sci B 2007;8:560-565.
35. Ojima T, Iwahashi M, Nakamori M et al. Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: An analysis of 689 consecutive cases managed by a single center. Arch Surg 2009;144:351-358.
36. Wagman LD. "Necessary" transfusions and prognosis in gastric cancer. Ann Surg Oncol 2002;9:1-2.
37. Memon MA, Khan S, Yunus RM, Barr R, Memon B. Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma. Surg Endosc 2008;22:1781-1789.
38. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-1376.
39. Winslow RM. New transfusion strategies: Red cell substitutes. Annu Rev Med 1999;50:337-353.
40. Remy B, Deby-Dupont G, Lamy M. Red blood cell substitutes: Fluorocarbon emulsions and haemoglobin solutions. Br Med Bull 1999;55:277-298.